EPRXNasdaq

EUPRAXIA PHARMACEUTICALS INC.

Pharmaceutical Preparations · A1 · CIK 1581178

Develops extended-release pharmaceutical alternatives for osteoarthritis and eosinophilic esophagitis using proprietary Diffusphere technology

$395M

Market cap

$6.59

Last close

-0.1%

-0.8%

356K

Volume

Price · last 39 sessions-11.2%

May 4L $5.92 · H $7.61Jun 29

Total filings

Jun 22, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance